PolyPid Ltd. (PYPD)
NASDAQ: PYPD · Real-Time Price · USD
4.760
+0.190 (4.16%)
At close: Jan 7, 2026, 4:00 PM EST
4.770
+0.010 (0.21%)
After-hours: Jan 7, 2026, 4:10 PM EST
PolyPid Employees
As of December 31, 2024, PolyPid had 60 total employees, including 57 full-time and 3 part-time employees. The number of employees decreased by 2 or -3.23% compared to the previous year.
Employees
60
Change (1Y)
-2
Growth (1Y)
-3.23%
Revenue / Employee
n/a
Profits / Employee
-$570,267
Market Cap
79.18M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 60 | -2 | -3.23% |
| Dec 31, 2023 | 62 | 2 | 3.33% |
| Dec 31, 2022 | 60 | -19 | -24.05% |
| Dec 31, 2021 | 79 | 10 | 14.49% |
| Dec 31, 2020 | 69 | 11 | 18.97% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
PYPD News
- 22 days ago - PolyPid Appoints Veteran MedTech Leader Brooke Story as Chairman of the Board of Directors - GlobeNewsWire
- 4 weeks ago - PolyPid Ltd. (PYPD) Discusses the Science and Business Case for D-PLEX100 in Tackling Surgical Site Infections Transcript - Seeking Alpha
- 5 weeks ago - PolyPid Announces Positive FDA Pre-NDA Meeting Minutes for D-PLEX₁₀₀ Supporting NDA Submission - GlobeNewsWire
- 6 weeks ago - PolyPid to Participate in ROTH Capital Partners Virtual KOL Event on December 10, 2025 - GlobeNewsWire
- 2 months ago - PolyPid Ltd. (PYPD) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - PolyPid Provides Corporate Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - PolyPid's D-PLEX₁₀₀ Wins BioTech Breakthrough Award for "Therapeutics Solution of the Year" - GlobeNewsWire
- 2 months ago - PolyPid to Report Third Quarter 2025 Financial Results and Operational Highlights on November 12, 2025 - GlobeNewsWire